The uncomfortable truth: transformative obesity medications come with transformative costs
p = 0.271)
[10] [11] Until more human data become available, a precautionary approach remains the standard of care
Cost considerations without insurance (as of 2025): Wegovy (semaglutide): approximately $1,300-$1,500 per month Saxenda (liraglutide): approximately $1,300-$1,400 per month Zepbound (tirzepatide): approximately $1,000-$1,200 per month These prices reflect list prices
Pairing peanut butter with low-GI foods such as apples, whole-grain bread, or oatmeal can further enhance its blood sugar-stabilizing effect
In addition, their impact on gastric motility has raised perioperative concerns, particularly related to delayed gastric emptying, which increases the risk of vomiting and aspiration during induction of general anesthesia